biomedicina slovenica

pr=Codreanu : 10

  1. Lauper Kim; Ludici Michele; Mongin Denis; Bergstra Sytske Anne; Choquette Denis; Codreanu Catalin; Cordtz René; De Cock Diederik; Dreyer Lene; Rotar Žiga
    Effectiveness of TNF-inhibitors, abatacept, IL6- inhibitors and JAK- inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK- pot’ collaboration
    2022 ►
  2. Lauper Kim; Mongin Denis; Bergstra S. A.; Choquette Denis; Codreanu Catalin; De Cock D.; Dreyer L.; Elkayam Ori; Hyrich Kimme; Rotar Žiga
    Heterogeneity in adverse event assessment between countries participating in an international collaboration of registries of rheumatoid arthritis patients using janus kinase inhibitors (the JAK-pot study)
    2021 ►
  3. Michelsen Brigitte; Lindström Ulf; Codreanu Catalin; Ciurea Adrian; Závada Jakub; Gitte Loft Anne; Pombo-Suarez Manuel; Onen Fatos; Rotar Žiga; Tomšič Matija
    Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment
    2020 ►
  4. Michelsen Brigitte; Lindström Ulf; Codreanu Catalin; Ciurea Adrian; Závada Jakub; Gitte Loft Anne; Pombo-Suarez Manuel; Onen Fatos; Rotar Žiga; Tomšič Matija
    Drug retention rates and treatment outcomes in 1860 axial spondyloarthritis patients treated with secukinumab in routine clinical practice in 13 European countries in the EuroSpA research collaboration network
    2020 ►
  5. Lauper Kim; Mongin Denis; Bergstra S. A.; Choquette Denis; Codreanu Catalin; De Cock D.; Dreyer L.; Elkayam Ori; Hyrich Kimme; Rotar Žiga
    Comparative effectiveness of JAK-inhibitors, TNF-inhibitors, abatacept and il-6 inhibitors in an international collaboration of registers of rheumatoid arthritis patients (the "JAK-pot" study)
    2020 ►
  6. Lauper Kim; Mongin Denis; Bergstra Sytske Anne; Choquette Denis; Codreanu Catalin; Elkayam Ori; Hyrich Kimme; Iannone Florenzo; Rotar Žiga
    Heterogeneity in the pattern of use of JAK- inhibitors between countries participating in an international collaboration of registers of rheumatoid arthritis patients (the JAK-pot Study)
    2019 ►
  7. Michelsen Brigitte; Askling Johan; Codreanu Catalin; Mann Herman; Gitte Loft Anne; Pombo-Suarez Manuel; Rotar Žiga; Kvien Tore K.; Santos Maria Jose; Tomšič Matija
    6 and 12- month drug retention rates and treatment outcomes in 941 patients with axial spondyloarthritis treated with secukinumab in routine clinical practice in 12 European countries in the EuroSpA Research Collaboration Network
    2019 ►
  8. Lauper Kim; Nordström Dan C.; Pavelka Karel; Hernández Maria Victoria; Kvien Tore K.; Kristianslund Eirik Klami; Santos Maria Jose; Rotar Žiga; Iannone Florenzo; Codreanu Catalin
    Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug
    2018 ►
  9. Ionescu Ruxandra; Rednic Simona; Praprotnik Sonja; Edwards Christopher; Codreanu Catalin
    Registre de reumatologie în Europa
    2017 ►
  10. Ebner Wolfgang; Palotai Tamas; Codreanu Catalin; Geher Pál; Pahor Artur; Pavelka Karel; Smolen Josef S.; Szechinski Jacek; Žlnay Martin
    Ankylosierende Spondylitis in Mittel- und Osteuropa: Querschnittsstudie zu Behandlungsmustern, Krankheitsaktivität und Lebensqualität
    2008 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics